Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
RUA Life Sciences plc · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Mar 2027 | $5.18M | $5.18M - $5.18M | -$2.70M | -$0.008 | 1 |
| Mar 2026 | $5.15M | $4.92M - $5.39M | -$2.68M | -$0.014 | 2 |
| Mar 2025 | $3.30M | $3.30M - $3.30M | -$27.05M | -$0.016 | 1 |
| Mar 2024 | $2.20M | $2.18M - $2.23M | -$14.89M | -$0.059 | 1 |
| Mar 2023 | $2.12M | $2.12M - $2.12M | -$8.21M | -$0.097 | 1 |
| Mar 2022 | $1.65M | $1.65M - $1.65M | -$5.67M | -$0.118 | 1 |
| Mar 2021 | $1.43M | $1.43M - $1.43M | -$2.60M | -$0.095 | 1 |
| Mar 2020 | $502.9K | $502.9K - $502.9K | -$337.1K | -$0.041 | 1 |
| Mar 2019 | $458.4K | $458.4K - $458.4K | -$307.3K | $0.00 | 2 |
| Mar 2018 | $406.3K | $406.3K - $406.3K | -$272.4K | $0.00 | 3 |
| Mar 2017 | $2.80M | $2.80M - $2.80M | -$1.88M | $0.00 | 3 |
| Mar 2016 | $1.46M | $1.46M - $1.46M | -$979.3K | $0.00 | 2 |